Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384659623> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W4384659623 abstract "Background The use of Bcr-Abl TKI was found to be associated with hepatitis B (HBV) flares, with a more profound risk observed in females. This study was conducted to characterize the clinical features of patients with HBV flare among Bcr-Abl TKI users, to estimate sex-specific incidence rates of HBV flare, and to evaluate potential cumulative effect of Bcr-Abl TKI. Methods Bcr-Abl TKI users with chronic HBV infection were identified from Taiwan's National Health Insurance database. The HBV flare cases were identified within the cohort. Incidence rates of HBV flare between men and women were assessed. Nested case–control analysis was used to evaluate the cumulative effect of Bcr-Abl TKI use on HBV flare. Results Among 415 patients with chronic HBV infection treated with Bcr-Abl TKI from 2005 through 2018, 45 flare cases (28 males and 17 females) were identified. Days between Bcr-Abl TKI initiation and HBV flare was 319 days in women compared to 610 days in men. 66.7% of the flares occurred during TKI therapy. Twelve of the 45 patients died, half of them died around 6 months after hepatitis B flare. Incidence rates of HBV flare were 2.34 and 3.33 per 100 person-years in males and females, respectively. Higher incidence was observed among patients with chronic myeloid leukemia. Cumulative effect of Bcr-Abl TKI on HBV flare was not observed. Conclusion Approximately 10% of HBV carriers who used Bcr-Abl TKI experienced HBV flare in Taiwan. The risk was higher in women and among patients with chronic myeloid leukemia." @default.
- W4384659623 created "2023-07-20" @default.
- W4384659623 creator A5001818085 @default.
- W4384659623 creator A5020870711 @default.
- W4384659623 creator A5029478162 @default.
- W4384659623 creator A5045255444 @default.
- W4384659623 date "2023-07-18" @default.
- W4384659623 modified "2023-09-23" @default.
- W4384659623 title "Sex‐specific incidence of hepatitis B virus flares among <scp>Bcr‐Abl</scp> tyrosine kinase inhibitor users in Taiwan" @default.
- W4384659623 cites W1994351795 @default.
- W4384659623 cites W2007113606 @default.
- W4384659623 cites W2028822747 @default.
- W4384659623 cites W2105652006 @default.
- W4384659623 cites W2117819389 @default.
- W4384659623 cites W2136202467 @default.
- W4384659623 cites W2499715519 @default.
- W4384659623 cites W2553957395 @default.
- W4384659623 cites W2590941489 @default.
- W4384659623 cites W2792735085 @default.
- W4384659623 cites W2896847025 @default.
- W4384659623 cites W2913217706 @default.
- W4384659623 cites W2943246216 @default.
- W4384659623 cites W2960526624 @default.
- W4384659623 cites W2979527477 @default.
- W4384659623 cites W2981062729 @default.
- W4384659623 cites W3031602500 @default.
- W4384659623 cites W3123427242 @default.
- W4384659623 cites W3141473743 @default.
- W4384659623 cites W3185229352 @default.
- W4384659623 cites W4285498169 @default.
- W4384659623 doi "https://doi.org/10.1002/pds.5667" @default.
- W4384659623 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37463800" @default.
- W4384659623 hasPublicationYear "2023" @default.
- W4384659623 type Work @default.
- W4384659623 citedByCount "0" @default.
- W4384659623 crossrefType "journal-article" @default.
- W4384659623 hasAuthorship W4384659623A5001818085 @default.
- W4384659623 hasAuthorship W4384659623A5020870711 @default.
- W4384659623 hasAuthorship W4384659623A5029478162 @default.
- W4384659623 hasAuthorship W4384659623A5045255444 @default.
- W4384659623 hasConcept C120665830 @default.
- W4384659623 hasConcept C121332964 @default.
- W4384659623 hasConcept C126322002 @default.
- W4384659623 hasConcept C159047783 @default.
- W4384659623 hasConcept C203014093 @default.
- W4384659623 hasConcept C2522874641 @default.
- W4384659623 hasConcept C2777382497 @default.
- W4384659623 hasConcept C2780593183 @default.
- W4384659623 hasConcept C61511704 @default.
- W4384659623 hasConcept C71924100 @default.
- W4384659623 hasConcept C72563966 @default.
- W4384659623 hasConcept C88879693 @default.
- W4384659623 hasConceptScore W4384659623C120665830 @default.
- W4384659623 hasConceptScore W4384659623C121332964 @default.
- W4384659623 hasConceptScore W4384659623C126322002 @default.
- W4384659623 hasConceptScore W4384659623C159047783 @default.
- W4384659623 hasConceptScore W4384659623C203014093 @default.
- W4384659623 hasConceptScore W4384659623C2522874641 @default.
- W4384659623 hasConceptScore W4384659623C2777382497 @default.
- W4384659623 hasConceptScore W4384659623C2780593183 @default.
- W4384659623 hasConceptScore W4384659623C61511704 @default.
- W4384659623 hasConceptScore W4384659623C71924100 @default.
- W4384659623 hasConceptScore W4384659623C72563966 @default.
- W4384659623 hasConceptScore W4384659623C88879693 @default.
- W4384659623 hasLocation W43846596231 @default.
- W4384659623 hasLocation W43846596232 @default.
- W4384659623 hasOpenAccess W4384659623 @default.
- W4384659623 hasPrimaryLocation W43846596231 @default.
- W4384659623 hasRelatedWork W1987405841 @default.
- W4384659623 hasRelatedWork W2014785051 @default.
- W4384659623 hasRelatedWork W2031510386 @default.
- W4384659623 hasRelatedWork W2046117397 @default.
- W4384659623 hasRelatedWork W2046653726 @default.
- W4384659623 hasRelatedWork W2059888761 @default.
- W4384659623 hasRelatedWork W2098654902 @default.
- W4384659623 hasRelatedWork W2275480158 @default.
- W4384659623 hasRelatedWork W2603773853 @default.
- W4384659623 hasRelatedWork W4238089809 @default.
- W4384659623 isParatext "false" @default.
- W4384659623 isRetracted "false" @default.
- W4384659623 workType "article" @default.